Treatment of mTBI Balance Dysfuntion via Multimodal Biofeedback.

Award Information
Agency:
Department of Defense
Branch
Defense Health Program
Amount:
$749,636.00
Award Year:
2011
Program:
SBIR
Phase:
Phase II
Contract:
W81XWH-10-C-0184
Agency Tracking Number:
O2-1122
Solicitation Year:
2009
Solicitation Topic Code:
OSD09-H22
Solicitation Number:
2009.3
Small Business Information
BalanceSense LLC
312 Acadia Lane, Celebration, FL, 34747-5001
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
Y
Duns:
961679979
Principal Investigator:
Karen Atkins
Research Scientist
(407) 625-9680
atkins.balancesense@gmail.com
Business Contact:
Karen Atkins
Pres/CEO
(407) 625-9680
atkins.balancesense@gmail.com
Research Institution:
Stub




Abstract
Multimodal Sensory Enrichment Device (SEMD) is a medical device system for the testing and training of static and dynamic postural control of sway in patients with dizziness, balance deficit, and/or movement disorders. SEMD provides vibrotactile, visual, and audio cueing referenced to center of pressure for postural control of small and large movement tasks, limited locomotion, dual tasking, and spatial orientation within a hierarchy of skill set protocols. Successful Phase I outcomes provide the basis for SEMD Phase II parallel military and clinical population clinical trials. Results from the clinical trials will: 1) standardize postural sway assessment tests, 2) develop multimodal treatment protocols, 3) establish SEMD efficacy in both military mTBI populations, and civilian populations that fall. Clinical trial results will 1) help refine the in-clinical device model software, 2) determine design specifications for the in-home exercise model, 3) establish regulatory pathways, 4) deliver manufacturing specifications, and 5) will guide the devices into Phase III commercialization.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government